Group 1: Wastewater Resource Utilization - The company focuses on wastewater resource utilization as a core business area, with significant breakthroughs in membrane technology and process innovation [2] - The fifth generation of MBR membrane modules has been developed, with the V-MBR technology achieving independent intellectual property rights and large-scale demonstration projects [2] - A representative project, the Meixi Lake Water Purification Plant, has a design capacity of 250,000 tons/day and was recognized as a national green low-carbon benchmark water plant in 2024 [2] Group 2: Industrial Water Treatment and Seawater Utilization - The company has successfully implemented multiple key projects in industrial water treatment, including projects in Liaoning and Shandong, showcasing its technical strength [3] - In seawater desalination, the company has achieved international leading levels in membrane product technology, with a desalination rate of 99.8% for the UF-RO dual membrane integration technology [3] - The integrated seawater utilization project in Huanghua City has a total investment of over 500 million RMB, combining water intake, pretreatment, desalination, and photovoltaic energy storage systems [3] Group 3: Salt Lake Resource Utilization - The company has made significant progress in salt lake resource utilization, developing six specialized adsorbents/membrane products and five integrated technologies [3] - The lithium extraction project at Zijin Mining's Tibet Arilagocuo Salt Lake has an annual capacity of 20,000 tons of lithium hydroxide, marking a global first for the "titanium-based adsorbent + membrane system" [3] - Future plans include expanding from salt lake resources to industrial valuable resource recovery and comprehensive utilization [3] Group 4: Pharmaceutical Membrane Business - The pharmaceutical membrane business was officially launched in 2023, focusing on life health separation and purification [4] - The company has formed a professional team of over 30 members and achieved breakthroughs in key areas such as protein separation and virus removal [4] - Notable applications include a CAR-T cell therapy project with nearly 100% recovery rate of lentivirus and a project that increased the concentration of traditional Chinese medicine exosomes by 20 times while maintaining 100% active ingredients [5] Group 5: Technology Iteration and Market Competitiveness - The company emphasizes technological innovation, achieving a 25% cost reduction in V-MBR equipment and a production speed increase to 20 meters/min for conventional reverse osmosis membranes [5] - The SC series ultra-pure water reverse osmosis membranes have achieved domestic substitution, enhancing international competitiveness [5] - Strategies to improve market share include large-scale production, benchmark project implementation, and promoting high-margin membrane products [5] Group 6: Accounts Receivable Management - The company is actively addressing accounts receivable issues through various measures, including tailored loss reduction plans and establishing a specialized collection team [5] - Efforts have been made to enhance internal management systems and involve local government debt resolution initiatives [5] - Future plans include optimizing collection strategies and improving internal controls to alleviate accounts receivable pressure [5]

Group 1: Company Overview and Strategy - Beijing Beishuiyuan Technology Co., Ltd. is a leading enterprise in the environmental high-tech sector, focusing on water treatment with a comprehensive industrial chain layout that includes membrane material R&D, manufacturing, and digital water management [2]. - The company is currently in a critical transformation phase towards a strategy termed "12256," emphasizing high innovation, intelligence, and environmental sustainability while balancing quality and efficiency [2]. - Traditional business remains stable, while new business areas such as wastewater resource utilization and high-quality drinking water are showing progress [2]. Group 2: Key Projects and Developments - In industrial water treatment, the company has secured multiple key projects, including the Liaoning Lighthouse Economic Development Zone industrial wastewater treatment project and the Liao Yuan High-tech Zone industrial wastewater plant [3]. - The company has achieved a desalination rate of 99.8% with its "UF-RO" dual membrane integration technology, and its annual production capacity for ultra-pure reverse osmosis membranes has reached 1 million square meters, with a maximum capacity of 3 to 7 million square meters [3]. - The Bohai New Area integrated seawater utilization project has a total investment exceeding 100 million yuan, integrating water intake, pretreatment, seawater desalination, and photovoltaic energy storage systems [3]. Group 3: Emerging Business Areas - The company has made significant advancements in lithium extraction from salt lakes, with projects like the 20,000 tons/year lithium hydroxide project using a titanium-based adsorbent and membrane system [3]. - The pharmaceutical membrane business was officially launched in 2023, focusing on protein separation and virus removal, with a professional team of over 30 members [3]. - Current revenue from the pharmaceutical membrane segment is still small, but the company plans to expand its market presence through continuous technological iterations and promotions [3]. Group 4: Technological Innovations and Market Competitiveness - The company has made key breakthroughs in membrane technology iterations and domestic replacements, including the fifth generation of MBR membrane modules and energy-saving membrane bioreactor technology [4]. - The production speed of conventional reverse osmosis membranes has increased to 20 meters per minute due to intelligent upgrades in production lines [4]. - The company has successfully replaced imported products with domestically produced ultra-pure water reverse osmosis membranes, enhancing its market share and profitability [4]. Group 5: Accounts Receivable Management - The company is actively addressing accounts receivable pressures through various measures, including tailored loss reduction plans for different projects and establishing a specialized collection team [4]. - Recent efforts have shown gradual success in recovering long-term accounts receivable, with ongoing strategies to optimize collection processes and enhance internal controls [4].

Group 1: Wastewater Resource Utilization - Wastewater resource utilization is a core business area, focusing on membrane technology iteration and process innovation [2] - The fifth generation of MBR membrane modules has been developed, with significant breakthroughs in structure and nitrogen removal processes [2] - The Meixi Lake wastewater treatment plant, with a design capacity of 250,000 tons/day, is a representative project, recognized as a national green low-carbon benchmark [2] Group 2: Seawater Desalination - The company is expanding into seawater desalination, previously a minor focus, with current technology matching international leaders [3] - The reverse osmosis membrane products achieve a desalination rate of 99.8%, with annual production capacity reaching 3 million square meters [3] - The Bohai New Area integrated seawater utilization project has a total investment exceeding 500 million yuan, aiming to become a new model for seawater desalination in Hebei Province [3] Group 3: Salt Lake Resource Utilization - Salt lake resource utilization is a new focus area, with the development of specialized adsorbents and integrated technologies [4] - The company has launched projects in Tibet and Qinghai, including a lithium extraction project using titanium-based adsorbents [4] - Future plans include expanding from salt lakes to industrial resource recovery, addressing various raw materials [4] Group 4: Biopharmaceutical Applications - The company has entered the biopharmaceutical sector, developing membranes for protein concentration and virus removal [5] - A professional team has been established, achieving breakthroughs in hollow fiber membrane design and manufacturing [5] - Initial applications include projects in CAR-T cell therapy and traditional Chinese medicine, with high recovery rates reported [5]

Core Viewpoint - The company's performance in 2024 declined significantly due to poor operating conditions of its key associate company, resulting in a substantial drop in net profit and revenue [2][3] Financial Performance - In 2024, the company achieved operating revenue of 8.549 billion yuan, a year-on-year decrease of 5% [1] - The net profit attributable to shareholders was 59 million yuan, down 92% year-on-year [1][2] - The non-recurring net profit was 33 million yuan, also down 92% year-on-year [1][2] - The associate company, Yunnan Water, reported operating revenue of 2.798 billion yuan, a decline of 11% year-on-year, and a net loss of 1.739 billion yuan, a decrease of 153% [2] Business Segments - Water treatment and ecological business generated revenue of 7.230 billion yuan, down 13% year-on-year, with a gross margin increase of 0.23 percentage points to 30.45% [2] - Municipal and water supply, along with optical technology business, saw a significant revenue increase of 92% year-on-year, totaling 1.320 billion yuan, with a gross margin increase of 8.97 percentage points to 21.73% [2] Order Growth and Market Expansion - The company experienced continuous growth in new orders, with 178 new EPC orders amounting to 11.714 billion yuan, and a total of 334 orders on hand valued at 9.648 billion yuan [3] - The company is actively expanding into overseas markets, including Malaysia, Mauritania, and Namibia, while exporting industrial reverse osmosis membranes to Dubai and household reverse osmosis membrane components to Mexico, Russia, and Italy [3] Research and Development - The R&D expenditure for 2024 was 343 million yuan, with an R&D expense ratio of 3.51%, an increase of 0.01 percentage points from 2023 [4] - The company is focusing on strategic emerging industries, particularly in seawater desalination, industrial zero discharge, and salt lake resource utilization [4] - The company developed a new series of high desalination rate, low energy consumption, and low leaching ultra-pure water reverse osmosis membranes, accelerating the domestic replacement of high-end membrane materials [4] Profit Forecast - The company is projected to achieve operating revenues of 9.017 billion yuan, 9.531 billion yuan, and 10.098 billion yuan for 2025-2027, with year-on-year growth rates of 5.47%, 5.70%, and 5.95% respectively [5] - The net profit attributable to shareholders is expected to be 231 million yuan, 262 million yuan, and 295 million yuan for the same period, with growth rates of 294.78%, 13.24%, and 12.47% respectively [5]